For individuals with diabetes, medications such as metformin, sulfonylureas, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, and insulin may be prescribed to manage blood sugar levels and reduce the risk of cardiovascular complications associated with diabetes. This evidence concerns the gene SLC5A2 and diabetes mellitus.